Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0OGPXK)
| ADC Name |
ASP2998
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
ASP2998
Click to Show/Hide
|
|||||
| Organization |
Astellas Pharma (Top20 MNC)
|
|||||
| Drug Status |
Phase 1/2
|
|||||
| Antibody Name |
Anti-TROP2 antibody
|
Antibody Info | ||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
Payload Info | ||||
| Payload Target |
Stimulator of interferon genes protein (STING1)+DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Undisclosed
|
|||||
2027 Update
The disease landscape of This ADC
2027 Update
The clinical trial pipelines of This ADC
| Disease Name | Phase 1 | Phase 2 | Phase 3 | Approved |
|---|---|---|---|---|
| Gastroesophageal junction adenocarcinoma | ||||
| Gastric cancer | ||||
| Lung cancer | ||||
| Breast cancer | ||||
| Urothelial cancer |